Shorter Versus Standard Antithyroid Drug Therapy in Graves’ Disease with Lower Baseline Thyrotropin Receptor Antibody (TRAb) Levels: Relapse Outcomes from a Propensity-Weighted Analysis
Salman Razvi, Mia Holley, Hannah Wheeler, Jonathan Vernazza, Kathryn Stewart, Simon H.S. Pearce, Kilimangalam Narayanan, and Vasileios Tsatlidis
